SHEBA MEDICAL CENTER
๐ฟ๐ฆSouth Africa
- Country
- ๐ฟ๐ฆSouth Africa
- Ownership
- Private
- Established
- 1948-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.sheba.co.il
Short Term Group Therapy for Anxiety Disorder
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2007-12-27
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00229281
- Locations
- ๐ฎ๐ฑ
Chaim Sheba Medical Center, Ramat-Gan, Israel
Fibromyalgia in Men Suffering From PTSD
Completed
- Conditions
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2007-12-27
- Lead Sponsor
- Sheba Medical Center
- Registration Number
- NCT00229294
TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis
Phase 3
- Conditions
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2006-08-29
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT00228228
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
Genotyping of Cytomegalovirus From Patients in Israel
- Conditions
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2006-08-18
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT00228202
- Locations
- ๐ฎ๐ฑ
Central Virology Laboratory, Chaim Sheba Medical Center Tel-Hashomer, Ramat Gan, Israel
T-Cell Vaccination in Multiple Sclerosis (MS)
Phase 1
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2007-01-24
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT00220428
- Locations
- ๐ฎ๐ฑ
Multiple Sclerosis Center, Ramat Gan, Israel
Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2007-01-05
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT00220493
- Locations
- ๐ฎ๐ฑ
Multiple Sclerosis Center, Ramat Gan, Israel
Fatigue Treatment Using Provigil
Not Applicable
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2006-02-17
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00220506
- Locations
- ๐ฎ๐ฑ
Multiple Sclerosis Center, Tel Hashomer, Israel
A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression
Not Applicable
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2010-02-09
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT00220480
- Locations
- ๐ฎ๐ฑ
Ness Ziona Mental Health Center, Ness Ziona, Israel
๐ฎ๐ฑRambam Medical Center, Haifa, Israel
๐ฎ๐ฑChaim Sheba Medical Center, Ramat-Gan, Israel
The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients.
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-08-12
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00156169
Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia
Phase 2
- Conditions
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2006-12-27
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT00138775
- Locations
- ๐ฎ๐ฑ
Shalvata Mental Health Center, Hod Hasharon, Israel
๐ฎ๐ฑShaar Menashe Mental Health Center, Shaar Menashe, Israel
๐ฎ๐ฑSheba Medical Center, Ramat-Gan, Israel
ยฉ Copyright 2024. All Rights Reserved by MedPath